Equities
Health CareMedical Equipment and Services
  • Price (JPY)2,541.50
  • Today's Change56.00 / 2.25%
  • Shares traded5.20m
  • 1 Year change+18.73%
  • Beta0.9353
Data delayed at least 20 minutes, as of May 17 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income35,854182,294149,873
Depreciation/depletion65,94066,74164,615
Non-Cash items76,737(7826)(12613)
Cash taxes paid, supplemental137,39097,5679,164
Cash interest paid, supplemental4,8035,3884,286
Changes in working capital(136166)(142719)(32146)
Total cash from operations42,36598,490169,729
INVESTING
Capital expenditures(64624)(70623)(61771)
Other investing and cash flow items, total424,61612,209(9245)
Total cash from investing359,992(58414)(71016)
FINANCING
Financing cash flow items(6430)(825)(1990)
Total cash dividends paid(20057)(17822)(15428)
Issuance (retirement) of stock, net(180002)(50003)(30001)
Issuance (retirement) of debt, net(69521)(74528)6,752
Total cash from financing(276010)(143178)(40667)
NET CHANGE IN CASH
Foreign exchange effects9,0746,04227,048
Net change in cash135,421(97060)85,094
Net cash-begin balance/reserved for future use205,512302,572217,478
Net cash-end balance/reserved for future use340,933205,512302,572
SUPPLEMENTAL INCOME
Depreciation, supplemental65,94066,74164,615
Cash interest paid, supplemental4,8035,3884,286
Cash taxes paid, supplemental137,39097,5679,164
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.